diseases of nose and paranasal sinuses J01 J00
Conditions
Interventions
Group 1: Patients suffering from rhinitis/ sinusitis use the nasal spray hysan Salinspray during the treatment period
1-2 puffs several times per day into each nostril
Sponsors
URSAPHARM Arzneimittel GmbH
Eligibility
Sex/Gender
All
Age
1 Years to No maximum
Inclusion criteria
Inclusion criteria: - Adults and children > 1 year - indication for Treatment with hysan Salinspray - doctor's decision to prescribe hysan Salinspray is independent from decistion to include the patient into the study
Exclusion criteria
Exclusion criteria: Due to the non-interventional character of the study, no exclusion criteria are predefined. Contraindications and interactions as described in the package leaflet must be considered.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Aims of the study (documentation in Case Report Form at beginning and end of the Treatment): Efficacy: Change in symptoms under Treatment: - nasal obstruction - sneezing attacks - runny nose - post-nasal discharge - thick nasal discharge - desire to clear one's throat/ dry throat - redness of the nasal mucosa - edema of the nasal mucosa - reduction of smell - reduction of taste - impairment of sleep - Impairment of food intake/ appetite Safety: - incidence of adverse reactions under treatment - judgement on tolerability of the treatment | — |
Countries
Germany
Contacts
Public ContactPeter Meiser
URSAPHARM Arzneimittel GmbH
Outcome results
None listed